Correlation of ACT as Measured with Three Commercially Available Devices with Circulating Heparin Level during Cardiac Surgery
J Extra Corpor Technol, 27 4 (1995) 197-200
Published online: 2023-08-18
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass
Han Li, Cyril Serrick, Vivek Rao and Paul M YipPerfusion 36 (6) 610 (2021)
https://doi.org/10.1177/0267659120949351
Evaluating the activity of low-molecular-weight heparin in preparations and substances
A. L. Berkovskii, E. V. Sergeeva, A. V. Suvorov and A. A. KozlovPharmaceutical Chemistry Journal 46 (4) 249 (2012)
https://doi.org/10.1007/s11094-012-0772-6
An Evaluation of Factors Affecting Activated Coagulation Time
Yvonne P.J. Bosch, Patrick W. Weerwind, Patty J. Nelemans, Jos G. Maessen and Baheramsjah MochtarJournal of Cardiothoracic and Vascular Anesthesia 26 (4) 563 (2012)
https://doi.org/10.1053/j.jvca.2012.03.011
A Comparison of Heparin Management Strategies in Infants Undergoing Cardiopulmonary Bypass
Nina A. Guzzetta, Tanya Bajaj, Tom Fazlollah, Fania Szlam, Elizabeth Wilson, Anna Kaiser, Steven R. Tosone and Bruce E. MillerAnesthesia & Analgesia 106 (2) 419 (2008)
https://doi.org/10.1213/01.ane.0000297290.03501.db
147 (2006)
https://doi.org/10.1007/3-7985-1646-4_9
Comparison of ACT point-of-care measurements: repeatability and agreement
Y PJ Bosch, Y M Ganushchak and D S de JongPerfusion 21 (1) 27 (2006)
https://doi.org/10.1191/0267659106pf844oa
The Effect of Temperature and Aprotinin During Cardiopulmonary Bypass on Three Different Methods of Activated Clotting Time Measurement
David Machin and Philip DevineThe Journal of ExtraCorporeal Technology 37 (3) 265 (2005)
https://doi.org/10.1051/ject/200537265
New technology, old standards: disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron
Christopher L Aylsworth, Faith Stefan, Karl Woitas, Randall H Rieger, Martin LeBoutillier and Verdi J DiSesaThe Annals of Thoracic Surgery 77 (3) 973 (2004)
https://doi.org/10.1016/S0003-4975(03)01660-6
Monitoring anticoagulation and hemostasis in cardiac surgery
Linda Shore-LessersonAnesthesiology Clinics of North America 21 (3) 511 (2003)
https://doi.org/10.1016/S0889-8537(03)00036-1
Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass
F. De Somer, Y. Van Belleghem, F. Caes, K. François, H. Van Overbeke, J. Arnout, Y. Taeymans and G. Van NootenThe Journal of Thoracic and Cardiovascular Surgery 123 (5) 951 (2002)
https://doi.org/10.1067/mtc.2002.120334
A Quick Anti-Xa-Activity-Based Whole Blood Coagulation Assay for Monitoring Unfractionated Heparin During Cardiopulmonary Bypass: A Pilot Investigation
Roland Hansen, Andreas Koster, Marian Kukucka, Fritz Mertzlufft and Herrmann KuppeAnesthesia & Analgesia 91 (3) 533 (2000)
https://doi.org/10.1213/00000539-200009000-00006
A Quick Anti-Xa-Activity-Based Whole Blood Coagulation Assay for Monitoring Unfractionated Heparin During Cardiopulmonary Bypass: A Pilot Investigation
Roland Hansen, Andreas Koster, Marian Kukucka, Fritz Mertzlufft and Herrmann KuppeAnesthesia & Analgesia 533 (2000)
https://doi.org/10.1097/00000539-200009000-00006